SEC22C: A Protein Involved in Vesicle Traffic and Potential Drug Target

Target Name: SEC22C

NCBI ID: G9117

SEC22C

SEC22C: A Protein Involved in Vesicle Traffic and Potential Drug Target

SEC22C, also known as SEC22 vesicle-trafficking protein-like 3, is a protein that is expressed in various cell types in the human body. It is a member of the SEC22 family of proteins, which are involved in the transport of vesicles, also known as small vesicles or secretory vesicles, from the endoplasmic reticulum to the cytosol.

SEC22C is a 22kDa protein that is expressed in a variety of tissues, including the brain, pancreas, and muscle. It is involved in the formation and maintenance of vesicles, which are specialized structures that are involved in the delivery of various types of molecules to cells in the body.

One of the unique features of SEC22C is its ability to interact with other proteins that are involved in the delivery of vesicles. This interaction allows SEC22C to play a role in the regulation of vesicle traffic, and is a potential drug target for the development of various diseases.

In addition to its role in vesicle traffic, SEC22C is also involved in the regulation of the formation and function of endoplasmic reticulum (ER) and cytosol. It is part of a complex that is involved in the delivery of vesicles to the ER, and is also involved in the degradation of vesicles that have failed to mature properly.

SEC22C is a protein that is expressed in a variety of tissues and is involved in the regulation of vesicle traffic. Its unique ability to interact with other proteins involved in vesicle delivery makes it a potential drug target for the development of various diseases. Further research is needed to fully understand the role of SEC22C in vesicle traffic and its potential as a drug target.

Protein Name: SEC22 Homolog C, Vesicle Trafficking Protein

Functions: May be involved in vesicle transport between the ER and the Golgi complex

The "SEC22C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEC22C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets